CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO), is currently up 0.61% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO), is currently up 0.34% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO), is currently up 0.32% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO), is up by 0.17% at lunch.
The Australian Dollar (AUD) is falling against the value of the US Dollar (USD) following interest rate changes in the USA.
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO), is up by 0.12% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO), is down by 0.15% at lunch.
Futures contracts for the S&P/ASX 200 (INDEXASX: XJO)(ASX: XJO) index are pointing to a slightly positive open on Friday morning, with CSL Limited (ASX: CSL) in the news.
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO), is up by 0.37% at lunch.
